Effect of Gd-EOB-DTPA on T2-weighted and diffusion-weighted images for the diagnosis of hepatocellular carcinoma

Journal of Magnetic Resonance Imaging

Volumn 32, Issue 1, 2010, Pages 229-234

  Saito, Kazuhiro ^a   Araki, Yoichi ^a   Park, Jinho ^a   Metoki, Ryo ^a   Katsuyama, Hiroaki ^a   Nishio, Ryota ^a   Kakizaki, Dai ^a   Moriyasu, Fuminori ^a   Tokuuye, Koichi ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Diffusion weighted image; Gd EOB DTPA; Hepatocellular carcinoma; Primovist; T2 weighted image

Indexed keywords

GADOXETIC ACID; CONTRAST MEDIUM; GADOLINIUM PENTETATE;

AGED; ARTICLE; CLINICAL EVALUATION; CONTRAST SENSITIVITY; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; INTERMETHOD COMPARISON; INTERRATER RELIABILITY; LIVER CELL CARCINOMA; LIVER PARENCHYMA; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHANTOM; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SIGNAL DETECTION; SIGNAL NOISE RATIO; T2 WEIGHTED IMAGING; TIME PERCEPTION; ANALYSIS OF VARIANCE; CARCINOMA, HEPATOCELLULAR; DIAGNOSTIC USE; DIFFERENTIAL DIAGNOSIS; DOSE RESPONSE; EVALUATION STUDY; IMAGE ENHANCEMENT; IMAGE QUALITY; LIVER; LIVER NEOPLASMS; OBSERVER VARIATION; PATHOLOGY; PROCEDURES; PROSPECTIVE STUDY; THREE DIMENSIONAL IMAGING; TIME;

AGED; ANALYSIS OF VARIANCE; CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; DIFFUSION MAGNETIC RESONANCE IMAGING; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; IMAGING, THREE-DIMENSIONAL; LIVER; LIVER NEOPLASMS; MALE; OBSERVER VARIATION; PHANTOMS, IMAGING; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 77954090252     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.22219     Document Type: Article

References (17)

1. Huppertz A, Haraida S, Kraus A, et al. Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT - initial observations. Radiology 2005;234:468-478. (Pubitemid 40139918)
2. Vogl TJ, Kummel S, Hammerstingl R, et al. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology 1996;200:59-67. (Pubitemid 26197732)
3. Schuhmann-Giampieri G, Achmitt-Willich H, Negishi WPC, Weinmann HJ, Speck U. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology 1992;183:59-64.
4. Hamm B, Staks T, Mühler A, et al. Phase 1 clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: pharmacokinetics, and MR imaging. Radiology 1995;195:785-792.
5. Zech CJ, Herrmann KA, Reiser MF, Schoenberg SO. MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA. Magn Reson Med Sci 2007;6:43-52.
6. Jeong YY, Mitchell DG, Holland GA. Liver lesion conspicuity: T2-weighted breath-hold fast spin-echo MR imaging before and after gadolinium enhancement - initial experience. Radiology 2001;219:455-460.
7. Chang SD, Thoeni RF. Effect of T1 shortening on T2-weighted MRI sequences: comparison of hepatic mass conspicuity on images acquired before and after gadolinium enhancement. AJR Am J Roentgenol 2008;190:1318-1323.
8. Brody JM, Schafer L, Tung GA, Breuer J, Shamsi K. Conspicuity of liver hemangiomas: short tau inversion recovery, T1, and T2 imaging with gadolinium ethoxybenzyl diethylenetriaminepenta-acetic acid. J Magn Reson Imging 2005;21:391-397. (Pubitemid 40446434)
9. Xu PJ, Yan FH, Wang JH, Lin J, Ji Y. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis. J Magn Reson Imging 2009;29:341-349.
10. Kamel IR, Liapi E, Reyes DK, Zahurak M, Bluemke DA, Gesch-wind JFH. Unresectable hepatocellular carcinoma: serial early vascular and cellular changes after transarterial chemoembolization as detected with MR imaging. Radiology 2009;250:466-473.
11. Chiu FY, Jao JC, Chen CY, et al. Effect of intravenous gadolinium-DTPA on diffusion-weighted magnetic resonance images for evaluation of focal hepatic lesions. J Comput Assist Tomogr 2005;29:176-180.
12. Bruix J, Sherman M. Management of Hepatocellular carcinoma. Hepatology 2005;42:1208-1236.
13. Tajima T, Honda H, Taguchi K, et al. Sequential hemodynamic change in hepatocellular carcinoma and dysplastic nodules: CT angiography and pathologic correlation. AJR Am J Roentgenol 2002;178:885-897.
14. Reimer P, Rummeny EJ, Shamsi K, et al. Phase 2 clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence. Radiology 1996;199:177-183.
15. Earls JP, Theise ND, Weinreb JC, et al. Dysplastic nodules and hepatocellular carcinoma: thin-section MR imaging of explanted cirrhotic liver with pathologic correlation. Radiology 1996;201:207-214.
16. Yamada K, Kubota H, Kizu O, et al. Effect of intravenous gadolinium-DTPA on diffusion-weighted images: evaluation of normal brain and infarcts. Stroke 2002;33:1799-1802.
17. Kim T, Murakami T, Hasuike Y, et al. Experimental hepatic dysfunction: evaluation by MRI with Gd-EOB-DTPA. J Magn Reson Imging 1997;7:683-688. (Pubitemid 28365618)